CLINICAL_TRIALS
safety_alert
· 2014-02-06
Clinical Trial Update: Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Summary
The update reports hepatitis B virus reactivation after withdrawal of preemptive antiviral therapy in patients with hematologic malignancies, underscoring safet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Seoul St. Mary's Hospital | Conditions: Lymphoma, Chronic Hepatitis B | Status: UNKNOWN